Atara Biotherapeutics (ATRA) Change in Taxes (2013 - 2014)
Atara Biotherapeutics (ATRA) posted Change in Taxes of -$62000.0 for Q4 2014, up 32.61% on a QoQ basis from -$92000.0 in Q1 2014, and down 145.26% year-over-year from $137000.0 in Q4 2013.
Atara Biotherapeutics (ATRA) Change in Taxes (2013 - 2014) Analysis & Trends
Atara Biotherapeutics' Change in Taxes history runs 2 years deep, the most recent figure standing at -$62000.0 for Q4 2014.
- Quarterly Change in Taxes fell 145.26% year-over-year to -$62000.0 in Q4 2014, while the trailing twelve-month figure through Dec 2014 was -$154000.0 (changed N/A YoY) and the FY2014 annual result came in at -$154000.0, down 204.05% from the prior year.
- Change in Taxes was -$62000.0 for Q4 2014 at Atara Biotherapeutics, up from -$92000.0 in the prior quarter.
- Across five years, Change in Taxes topped out at $137000.0 in Q4 2013 and bottomed at -$92000.0 in Q1 2014.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Atara Biotherapeutics | 110.04 Mn | 101.68 Mn | 392,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | -62,000.00 |
| Dec 31, 2014 | -62,000.00 |
| Mar 31, 2014 | -92,000.00 |
| Mar 31, 2014 | -92,000.00 |
| Dec 31, 2013 | 137,000.00 |
| Dec 31, 2013 | 137,000.00 |